JKHY vs PPCB · P/E 30, rev $2.54B vs P/E 0.0, $3.9M cap
Jack Henry & Associates Inc (JKHY) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
PPCB does not have a complete income-statement cache yet.
JKHY currently screens at market cap $12.76B and trailing P/E 29.8. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the JKHY and PPCB stock pages for the full models.
Not investment advice.